Innoviva Warns Of Bad Precedent Risk In Proxy Drop Battle
An attorney for drug licensing company Innoviva Inc. warned Friday that the Chancery Court could set a "dangerous precedent" if it upholds an investor's claim that Innoviva breached an oral contract...To view the full article, register now.
Already a subscriber? Click here to view full article